Private introduction
We listen to your goals, explain our role and identify the records a hospital may need.
Independent, patient-centred support for people exploring hospital-led CAR-T assessment and treatment in Shanghai — from initial record review to travel, interpretation and follow-up planning.
No treatment guarantees. Medical decisions are made solely by qualified hospital clinicians after assessment.
Built around informed choice
About CellBridge
CellBridge is a UK-registered healthcare coordination company supporting international patients exploring advanced medical treatment options in Shanghai, China.
We provide independent coordination support throughout the patient journey, including initial case communication, medical documentation support, hospital coordination, travel arrangements and ongoing liaison.
Our role is non-clinical.CellBridge does not provide medical diagnosis or treatment. All medical decisions are made by qualified healthcare professionals at the treating institution.
Why explore Shanghai?
Shanghai is home to major hospitals and specialist haematology and oncology teams. Availability, regulatory status, eligibility criteria and clinical pathways vary by hospital and can change.
We help patients approach this landscape carefully, seeking case-specific information from the treating institution. We do not rank hospitals, recommend a therapy as suitable, or present investigational options as established treatment.
The coordination pathway
Every case is different. This is an indicative pathway, not a promise of treatment or timing.
We listen to your goals, explain our role and identify the records a hospital may need.
With your consent, we organise and translate relevant medical information for hospital review.
A qualified clinical team decides whether further consultation, testing or treatment may be appropriate.
If invited to proceed, we help you understand the hospital’s proposed pathway, indicative costs and practical requirements.
Travel preparation, appointment coordination and language support are arranged around the hospital plan.
We help organise discharge documents and communication for follow-up with your home clinical team.
Partner hospital coordination
We coordinate with treating institutions on a case-by-case basis. Hospitals retain full responsibility for assessment, acceptance and clinical care.
Introductions, appointment scheduling and document exchange with selected hospital teams.
Professional language support for consultations and key written information where available.
Guidance on visas, accommodation, local transport and realistic companion arrangements.
Separation of hospital charges, third-party travel costs and our coordination fees before commitment.
Support organising records for your clinicians at home. We do not replace local follow-up care.
Safety & compliance
Coordinate information, appointments, travel and language support with your consent.
Diagnose, prescribe, provide treatment, guarantee eligibility, outcomes or timelines.
Only the responsible clinical team can assess suitability and explain benefits, risks and alternatives.
You should discuss overseas care with your current clinician and seek independent medical advice.
CAR-T can cause serious or life-threatening adverse effects and requires specialist monitoring.
Health information should only be shared through agreed secure channels and with explicit consent.
Common questions
No. We can help assemble information for hospital review, but only a qualified clinical team can determine whether further assessment or treatment is appropriate.
No. A hospital may decline a case, request more tests, recommend a different approach or change a plan after in-person assessment.
Costs vary substantially. Before you decide, we aim to distinguish hospital estimates, coordination fees and third-party travel costs. Estimates are not final bills.
We encourage you to involve your home clinical team. With consent, we can help organise records and discharge information, but their participation cannot be guaranteed.
We do not promise trial access. If a hospital identifies a research study, its team must explain the study status, eligibility, consent process, alternatives and costs.
Begin carefully
For an initial discussion, it helps to know your diagnosis, current treating country, previous therapies and what you hope to understand.